The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Prime - I am all for armies marching so will also be sending Maggie Throup and email.
Have sent an email to Maggie Throup, Parliamentary Under-Secretary (Department of Health and Social Care). To ask who the second validated supplier is and to point out some "home truths" with regard to "support of the UK Diagnistics indudtry"
IF I get a reply I'll post it so we can all have a laugh and cheer ourselves up @
"and provided investment in capital equipment and facilities expansion at three UK manufacturing companies?."
https://atamis-1928.cloudforce.com/sfc/p/#0O000000rwim/a/4J000000kGWF/r6IZcQe9syh4ZG0xns783ALda6NOsCOYeodrO0HjEcE
7.1 The Authority shall:
7.1.1 provide the Machinery and Tooling to the Supplier as set out in the Award Form, Schedule 2 (Specification), Schedule 3 (Commercial Model) and Schedule 35 (Lease Terms);
So Surescreen got Machinery and Tooling supplied by the government also, It looks more and more like the failure of the Mologic test to pass PHE was the nail in the Coffin for ODX and GAD. Donkey King an the BoD (including Jag) would have surely known that !
Definitely not Abingdon-Health;they still havent paid their bill!!
"and provided investment in capital equipment and facilities expansion at three UK manufacturing companies?."
Three?, not just ODX and GAD, so again we assume this is Surescreen, but where is the awards notifications and transparency docs?
Gawd knows, surescreen and surescreen possibly !
The 100m sounds like surescreen output
Under 1% rise yesterday after what seemed like a 6 month drop, now down nearly 6% today, feels like a kick in the teeth.
To be deployed in Jan 2022, still time for a surprise!
https://questions-statements.parliament.uk/written-questions/detail/2022-01-04/96746
"19 January 2022
In October 2020, the Government commissioned work to support the United Kingdom’s diagnostic industry, to secure a lateral flow antigen test and increase domestic production capacity. The UK Make programme delivered two clinically validated and regulatory approved UK lateral flow antigen tests? and provided investment in capital equipment and facilities expansion at three UK manufacturing companies?. Over 100 million tests were produced for deployment by the UK Health Security Agency and production capacity of lateral flow antigen test increased by 3,500%. The first UK-made self-test lateral flow device is currently due to be deployed in January 2022. The UK Make programme has also increased capacity and resilience for current and future public health challenges?."
"The UK Make programme delivered two clinically validated and regulatory approved UK lateral flow antigen tests?"
two approved tests, Surescreen and ?